State laws and prescribing rates of generic drugs in dermatology: a cross-sectional analysis of 2020 Medicare Part D claims data-Reference-Cited by-同舟云学术

State laws and prescribing rates of generic drugs in dermatology: a cross-sectional analysis of 2020 Medicare Part D claims data

Published:2023-09-15 Issue:10 Volume:315 Page:2991-2993
ISSN:1432-069X
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Diaz Michael Joseph,Tran Jasmine Thuy,Forouzandeh Mahtab

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00403-023-02719-x.pdf

Reference5 articles.

1. Mazmudar RS, Tripathi R, Bordeaux JS, Scott JF (2022) Trends in brand and generic drug utilization for dermatology providers from 2013–2019. Arch Dermatol Res. https://doi.org/10.1007/s00403-022-02431-2

2. Generic Pharmaceutical Association. Generic Drugs Continue to Deliver Billions in Savings to the U.S. Healthcare System, New Report Finds 2016. . Accessed Jul 25, 2023

3. Rome BN, Sarpatwari A, Kesselheim AS (2022) State laws and generic substitution in the year after new generic competition. Value Health 25(10):1736–1742. https://doi.org/10.1016/j.jval.2022.03.012. (Epub 2022 Apr 26. PMID: 35487821)

4. Bhatt MD, Bhatt BD, Dorrian JT, McLellan BN (2019) Increased topical generic prices by manufacturers. J Am Acad Dermatol 80(5):1353–1357. https://doi.org/10.1016/j.jaad.2018.03.004. (Epub 2018 Mar 12. PMID: 29544742)

5. Alghanem N, Abokwidir M, Fleischer AB Jr., Feldman SR, Alghanem W (2017) Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States. J Dermatolog Treat 28(2):119–128. https://doi.org/10.1080/09546634.2016.1182614. (Epub 2016 May 31. PMID: 27241622)